Low dose naltrexone compounding

Low Dose Naltrexone

Reduce Inflammation

LDN consultation

What Is Low Dose Naltrexone?

There are a number of proven solutions for reducing inflammation. One such option is low dose naltrexone — commonly called LDN — which refers to naltrexone taken at a fraction of the standard dose: typically 1.5 mg to 4.5 mg per day, compared to the commercially available 50 mg tablet used for addiction medicine.

At this lower dose, naltrexone works through an entirely different mechanism — one that researchers believe may gently modulate the immune system and support the body's natural anti-inflammatory pathways.

Because the 50 mg commercial dose cannot be divided safely or accurately to these levels, LDN is only available through a compounding pharmacy. There is no FDA-approved LDN product — every prescription must be individually prepared.

Conditions

Conditions Where LDN Is Being Explored

Autoimmune and Inflammatory Conditions

LDN has received growing attention in the clinical research community as an adjunct therapy for conditions driven by immune dysregulation. Patients and prescribers have explored LDN in:

  • Multiple sclerosis (MS)
  • Lupus (systemic lupus erythematosus)
  • Rheumatoid arthritis
  • Crohn's disease and ulcerative colitis
  • Hashimoto's thyroiditis
  • Psoriasis and psoriatic arthritis

Chronic Pain and Fibromyalgia

LDN's proposed anti-inflammatory and glial-modulating effects have made it a subject of interest for patients with conditions involving central sensitization and persistent pain, including:

  • Fibromyalgia
  • Complex regional pain syndrome (CRPS)
  • Chronic fatigue syndrome (ME/CFS)
  • Long COVID and post-viral syndromes

Emerging Mental Health Applications

Early-stage research is also exploring LDN's potential role in mood regulation and neurological conditions, including:

  • Treatment-resistant depression
  • Autism spectrum disorder (ASD) — symptom management
  • PTSD and anxiety-related conditions
LDN dosing support

How LDN Dosing Works

LDN is almost always started at a low dose — often as low as 0.5 mg to 1.5 mg — and gradually titrated upward over weeks. This approach helps minimize initial side effects (most commonly, vivid dreams or mild sleep disturbance in the early weeks) and allows the prescribing clinician to find the therapeutic level that works best for each individual.

Because titration is essential to success, compounding pharmacies are uniquely suited to support LDN therapy: we can prepare capsules at any specific strength your prescriber designates throughout the titration process.

Why Voshell's for LDN?

Our compounded LDN formulations give prescribers the flexibility to meet diverse patient needs. Every strength is prepared fresh at our Baltimore pharmacy under USP-compliant standards, with pharmacist support available for prescriber questions on dosing and titration.

Precise dosing

capsules compounded at exact prescribed strengths from 0.1 mg to 4.5 mg

Flexible strengths

0.1 mg, 0.5 mg, 1.5 mg, 2 mg, 3 mg, and 4.5 mg — the full therapeutic range

Micro-dosing support

customized ultra-low starting doses for sensitive patients or complex titration plans

Bulk prescription options

30-, 60-, and 90-count quantities to support ongoing treatment plans

Compounding

What to Expect From Your LDN Compound

At Voshell's Pharmacy, LDN is most commonly prepared as:

  • Capsules: the most common delivery form, prepared at the exact prescribed strength
  • Liquid formulations: useful for very fine dose adjustments during titration or for patients who cannot swallow capsules

We prepare each batch with careful attention to uniformity and dose accuracy — because with LDN, the dose is the therapy.

#LDN may be appropriate for your condition

LDN compounded medication

Compliance Note

LDN is prescribed off-label for most of the conditions listed above. Compounded LDN is not FDA-approved. Clinical evidence varies by condition and is ongoing. All LDN therapy requires a valid prescription from a licensed prescriber. Compounded medications may not be appropriate for all patients.